Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity
A series of novel 2,4-diaminoquinazoline derivatives were designed, synthesized, and evaluated as p21-activated kinase 4 (PAK4) inhibitors. All compounds showed significant inhibitory activity against PAK4 (half-maximal inhibitory concentration IC50 < 1 μM). Among them, compounds 8d and 9c de...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/23/2/417 |
id |
doaj-3d0076aed0404249919b4424bc10dd13 |
---|---|
record_format |
Article |
spelling |
doaj-3d0076aed0404249919b4424bc10dd132020-11-25T01:58:24ZengMDPI AGMolecules1420-30492018-02-0123241710.3390/molecules23020417molecules23020417Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition ActivityTianxiao Wu0Yu Pang1Jing Guo2Wenbo Yin3Mingyue Zhu4Chenzhou Hao5Kai Wang6Jian Wang7Dongmei Zhao8Maosheng Cheng9Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaA series of novel 2,4-diaminoquinazoline derivatives were designed, synthesized, and evaluated as p21-activated kinase 4 (PAK4) inhibitors. All compounds showed significant inhibitory activity against PAK4 (half-maximal inhibitory concentration IC50 < 1 μM). Among them, compounds 8d and 9c demonstrated the most potent inhibitory activity against PAK4 (IC50 = 0.060 μM and 0.068 μM, respectively). Furthermore, we observed that compounds 8d and 9c displayed potent antiproliferative activity against the A549 cell line and inhibited cell cycle distribution, migration, and invasion of this cell line. In addition, molecular docking analysis was performed to predict the possible binding mode of compound 8d. This series of compounds has the potential for further development as PAK4 inhibitors for anticancer activity.http://www.mdpi.com/1420-3049/23/2/417p21-activated kinasePAK4 inhibitor2,4-diaminoquinazolineanticancer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tianxiao Wu Yu Pang Jing Guo Wenbo Yin Mingyue Zhu Chenzhou Hao Kai Wang Jian Wang Dongmei Zhao Maosheng Cheng |
spellingShingle |
Tianxiao Wu Yu Pang Jing Guo Wenbo Yin Mingyue Zhu Chenzhou Hao Kai Wang Jian Wang Dongmei Zhao Maosheng Cheng Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity Molecules p21-activated kinase PAK4 inhibitor 2,4-diaminoquinazoline anticancer |
author_facet |
Tianxiao Wu Yu Pang Jing Guo Wenbo Yin Mingyue Zhu Chenzhou Hao Kai Wang Jian Wang Dongmei Zhao Maosheng Cheng |
author_sort |
Tianxiao Wu |
title |
Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity |
title_short |
Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity |
title_full |
Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity |
title_fullStr |
Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity |
title_full_unstemmed |
Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity |
title_sort |
discovery of 2-(4-substituted-piperidin/piperazine-1-yl)-n-(5-cyclopropyl-1h-pyrazol-3-yl)-quinazoline-2,4-diamines as pak4 inhibitors with potent a549 cell proliferation, migration, and invasion inhibition activity |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2018-02-01 |
description |
A series of novel 2,4-diaminoquinazoline derivatives were designed, synthesized, and evaluated as p21-activated kinase 4 (PAK4) inhibitors. All compounds showed significant inhibitory activity against PAK4 (half-maximal inhibitory concentration IC50 < 1 μM). Among them, compounds 8d and 9c demonstrated the most potent inhibitory activity against PAK4 (IC50 = 0.060 μM and 0.068 μM, respectively). Furthermore, we observed that compounds 8d and 9c displayed potent antiproliferative activity against the A549 cell line and inhibited cell cycle distribution, migration, and invasion of this cell line. In addition, molecular docking analysis was performed to predict the possible binding mode of compound 8d. This series of compounds has the potential for further development as PAK4 inhibitors for anticancer activity. |
topic |
p21-activated kinase PAK4 inhibitor 2,4-diaminoquinazoline anticancer |
url |
http://www.mdpi.com/1420-3049/23/2/417 |
work_keys_str_mv |
AT tianxiaowu discoveryof24substitutedpiperidinpiperazine1yln5cyclopropyl1hpyrazol3ylquinazoline24diaminesaspak4inhibitorswithpotenta549cellproliferationmigrationandinvasioninhibitionactivity AT yupang discoveryof24substitutedpiperidinpiperazine1yln5cyclopropyl1hpyrazol3ylquinazoline24diaminesaspak4inhibitorswithpotenta549cellproliferationmigrationandinvasioninhibitionactivity AT jingguo discoveryof24substitutedpiperidinpiperazine1yln5cyclopropyl1hpyrazol3ylquinazoline24diaminesaspak4inhibitorswithpotenta549cellproliferationmigrationandinvasioninhibitionactivity AT wenboyin discoveryof24substitutedpiperidinpiperazine1yln5cyclopropyl1hpyrazol3ylquinazoline24diaminesaspak4inhibitorswithpotenta549cellproliferationmigrationandinvasioninhibitionactivity AT mingyuezhu discoveryof24substitutedpiperidinpiperazine1yln5cyclopropyl1hpyrazol3ylquinazoline24diaminesaspak4inhibitorswithpotenta549cellproliferationmigrationandinvasioninhibitionactivity AT chenzhouhao discoveryof24substitutedpiperidinpiperazine1yln5cyclopropyl1hpyrazol3ylquinazoline24diaminesaspak4inhibitorswithpotenta549cellproliferationmigrationandinvasioninhibitionactivity AT kaiwang discoveryof24substitutedpiperidinpiperazine1yln5cyclopropyl1hpyrazol3ylquinazoline24diaminesaspak4inhibitorswithpotenta549cellproliferationmigrationandinvasioninhibitionactivity AT jianwang discoveryof24substitutedpiperidinpiperazine1yln5cyclopropyl1hpyrazol3ylquinazoline24diaminesaspak4inhibitorswithpotenta549cellproliferationmigrationandinvasioninhibitionactivity AT dongmeizhao discoveryof24substitutedpiperidinpiperazine1yln5cyclopropyl1hpyrazol3ylquinazoline24diaminesaspak4inhibitorswithpotenta549cellproliferationmigrationandinvasioninhibitionactivity AT maoshengcheng discoveryof24substitutedpiperidinpiperazine1yln5cyclopropyl1hpyrazol3ylquinazoline24diaminesaspak4inhibitorswithpotenta549cellproliferationmigrationandinvasioninhibitionactivity |
_version_ |
1724969902134001664 |